List of insiders holdings for Eiger BioPharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| KAYNE RICHARD A 10% Owner | 2023-11-02 21:21:30 | 0 5,375,225 | 5,375,225 | Form 4 |
| KAWAS LEEN 10% Owner | 2023-11-02 21:14:42 | 0 4,391,432 | 4,391,432 | Form 4 |
| Kordel Johan Director | 2014-02-06 15:44:42 | 0 1,774,349 | 1,774,349 | Form 4 |
| ZSEBO KRISZTINA M Chief Executive Officer | 2015-04-07 16:38:03 | 1,301,188 0 | 1,301,188 | Form 4 |
| Foley Todd Director | 2014-02-06 16:30:32 | 0 1,084,292 | 1,084,292 | Form 4 |
| INTERWEST PARTNERS X LP InterWest Management Partners X LLC Kliman Gilbert H ORONSKY ARNOLD L Desai Keval NASR KHALED 10% Owner | 2019-02-06 16:08:01 | 935,428 0 | 935,428 | Form 13D |
| INTERWEST PARTNERS X LP InterWest Management Partners X LLC CLEVELAND BRUCE A GIANOS PHILIP T Holmes W Stephen Kliman Gilbert H ORONSKY ARNOLD L Desai Keval NASR KHALED 10% Owner | 2019-02-06 16:08:01 | 935,428 0 | 935,428 | Form 13D |
| Apelian David CEO | 2023-07-06 17:37:37 | 750,000 0 | 750,000 | Form 4 |
| Cory David A President and CEO | 2022-03-11 21:06:19 | 450,183 0 | 450,183 | Form 4 |
| EcoR1 Capital LLC 10% Owner | 2020-02-14 14:29:18 | 449,338 0 | 449,338 | Form 13G |
| Cleveland Paul B President and CFO | 2015-01-05 20:51:16 | 417,500 0 | 417,500 | Form 4 |
| LABA REBECQUE J VP, Corporate Operations | 2015-04-03 16:12:17 | 305,359 0 | 305,359 | Form 4 |
| WIKLUND FREDRIK See Remarks | 2015-01-05 20:36:27 | 216,368 0 | 216,368 | Form 4 |
| RUDY JEFFREY J VP, Clinical Operations | 2015-01-12 18:28:05 | 182,762 0 | 182,762 | Form 4 |
| REED ELIZABETH E VP, General Counsel | 2015-01-05 20:44:47 | 142,669 0 | 142,669 | Form 4 |
| TAKEYA RYAN K VP, Manufacturing | 2015-04-03 16:09:13 | 141,006 0 | 141,006 | Form 4 |
| PFIZER INC 10% Owner | 2016-04-04 16:14:49 | 121,899 0 | 121,899 | Form 13G |
| Vollins James General Counsel | 2023-05-02 16:30:36 | 120,000 0 | 120,000 | Form 4 |
| Shaffer James P Chief Business Officer | 2021-03-15 19:41:10 | 100,546 0 | 100,546 | Form 4 |
| Patton Stephana Eilene See Remarks | 2021-03-15 19:36:03 | 89,198 0 | 89,198 | Form 4 |
| WELCH JAMES H Chief Financial Officer | 2018-03-16 20:14:23 | 60,000 0 | 60,000 | Form 4 |
| Mayer Eldon C. III Ex VP & Chief Commerc. Officer | 2023-03-21 21:00:25 | 56,073 0 | 56,073 | Form 4 |
| Choong Ingrid Chief Business Officer | 2023-09-05 21:38:59 | 54,000 0 | 54,000 | Form 4 |
| NARACHI MICHAEL Director | 2015-06-05 18:26:34 | 50,000 0 | 50,000 | Form 4 |
| Ryali Sriram Chief Financial Officer | 2022-03-14 21:22:50 | 41,566 0 | 41,566 | Form 4 |
| COOPER GRAHAM K Director | 2015-06-05 18:24:48 | 40,000 0 | 40,000 | Form 4 |
| Dietz Thomas John Director | 2023-03-03 20:49:50 | 40,000 0 | 40,000 | Form 4 |
| Alton Gregg H Director | 2015-06-05 18:24:03 | 40,000 0 | 40,000 | Form 4 |
| Jackson Andrew C. See Remarks | 2015-03-17 20:10:21 | 36,437 0 | 36,437 | Form 3 |
| Martins Eduardo Bruno SVP, Liver and Infectious Dise | 2017-03-14 19:33:46 | 30,000 0 | 30,000 | Form 4 |
| Sablich Kim Director | 2023-03-03 20:50:03 | 28,000 0 | 28,000 | Form 4 |
| Kelly-Croswell Lisa Director | 2023-03-03 20:49:57 | 28,000 0 | 28,000 | Form 4 |
| Glenn Jeffrey S Director | 2023-03-03 20:50:10 | 28,000 0 | 28,000 | Form 4 |
| Murray Christine Director | 2023-03-03 20:50:16 | 28,000 0 | 28,000 | Form 4 |
| Loh Evan Director | 2023-03-03 20:50:26 | 28,000 0 | 28,000 | Form 4 |
| Sachdev Amit Director | 2023-03-03 20:50:28 | 28,000 0 | 28,000 | Form 4 |
| Atkisson Erik GC & Chief Compliance Officer | 2023-01-30 21:15:13 | 26,750 0 | 26,750 | Form 4 |
| Honig Peter Director | 2015-06-05 18:25:54 | 22,800 0 | 22,800 | Form 4 |
| Quan Joanne Chief Medical Officer | 2018-04-04 17:18:58 | 22,256 0 | 22,256 | Form 4 |
| ENGLEMAN EDGAR Director 10% Owner | 2017-04-13 19:12:51 | 10000 0 | 10000 | Form 4 |
| Kjellson Nina S Director | 2017-04-14 14:32:05 | 10000 0 | 10000 | Form 4 |
| Bramlage Charles Director | 2017-04-13 19:23:26 | 10000 0 | 10000 | Form 4 |
| Yang Patrick Y Director | 2014-05-21 16:17:37 | 10000 0 | 10000 | Form 4 |
| Funder Joshua Director | 2014-05-21 16:14:50 | 10000 0 | 10000 | Form 4 |
| Vivo Ventures VI LLC Vivo Ventures Fund VI L.P. VIVO VENTURES VI AFFIILATES FUND L.P. 10% Owner | 2022-02-11 17:23:02 | 4166 0 | 4166 | Form 13D |
| RA CAPITAL MANAGEMENT LLC Kolchinsky Peter RA Capital Healthcare Fund LP 10% Owner | 2020-02-14 16:34:18 | 0 0 | 0 | Form 13G |
| Dalton Barbara Director | 2014-01-29 19:37:58 | 0 0 | 0 | Form 3 |
| Kachioff William G CFO | 2023-04-14 18:42:03 | 0 0 | 0 | Form 3 |
| Novartis Bioventures Ltd 10% Owner | 2016-01-07 16:05:30 | 0 0 | 0 | Form 13G |
| Lundbeckfond Invest A/S 10% Owner | 2016-01-29 07:27:36 | 0 0 | 0 | Form 13G |
| Enterprise Partners Management LLC 10% Owner | 2016-01-05 16:01:43 | 0 0 | 0 | Form 13G |
| Enterprise Partners Management LLC Enterprise Partners Liquidating Trust V Enterprise Partners Liquidating Trust VI 10% Owner | 2016-01-05 16:01:43 | 0 0 | 0 | Form 13G |